We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,090

Dispelling the Myriad gene patent harmonization myth
  • Foley & Lardner LLP
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the


German fixed price system infringes EU
  • Clifford Chance LLP
  • European Union, Germany
  • October 21 2016

With today's judgment the European Court of Justice ("ECJ") has ruled that the German fixed price system for prescription-only medicinal products


Health Law Newsletter (Portugal) - October 2016: Case Law
  • Cuatrecasas Gonçalves Pereira
  • European Union, Germany
  • November 11 2016

On 19 October 2016, the Court of Justice of the European Union (ECJ) ruled on request for a preliminary ruling from the Association Against German


Privacy & cybersecurity update, issue 3 - October, 2014
  • Jones Day
  • Australia, Brazil, Canada, Chile, China, USA, Japan, Mexico, Netherlands, New Zealand, Russia, Taiwan, European Union, France, Germany, Hong Kong, Ireland, Italy
  • October 15 2014

On August 1, the Federal Trade Commission ("FTC") issued a report on mobile shopping applications. In it, the FTC found that such apps often fail to


EU & Competition Law Review 10 November 2016
  • Roschier
  • European Union, France, Germany
  • November 10 2016

On 7 November 2016, the European Ombudsman ("Ombudsman") published a decision finding no maladministration by the Commission in its handling of a


Associations calls for better protection of consumers in draft law on e-health
  • Squire Patton Boggs
  • Germany
  • March 23 2015

The Federation of German Consumer Organisations (Vebraucherzentrale Bundesverband (VZBV)) recently criticized the new draft law on e-health stating


Infringement of second medical use patents
  • Taylor Wessing
  • Germany, United Kingdom
  • March 4 2015

With the increase in off-label prescribing in Europe, some argue that the carve-outs used by generic firms (see "Skinny labelling and the blue box


New German law proposed regarding anti-corruption in the healthcare sector
  • Hogan Lovells
  • Germany
  • February 10 2015

The German Ministry of Justice recently provided a new draft anticorruption law explicitly referring to the healthcare sector. If adopted, this law


A major step forward in CRPD compliance by the German Federal Constitutional Court?
  • 39 Essex Chambers
  • European Union, Germany
  • November 18 2016

Legislatures and courts worldwide, when they consider medical treatment and other measures in the context of intellectual


Acute impact decision on descriptive additions to pharmaceutical brand names
  • Latham & Watkins LLP
  • Germany
  • August 8 2013

The Higher Administrative Court of Northrhine-Westphalia (Oberverwaltungsgericht NRW OVG-NRW) has upheld a decision by the Administrative Court of